Indian pharma companies set to see 9-11% growth in FY25, says Icra
Indian pharmaceutical companies are set to experience 9-11 per cent revenue growth in FY25, driven by strong performances in key markets such as the United States, Europe, and emerging regions,…
What is attracting private equity funds to Indian pharma?
Scan any verbiage, online or in print, on Indian pharma and you are unlikely to miss space devoted to some of India’s leading pharma promoters contemplating a stake sale, either…